Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Mercearia para residentes do sudeste dos EUA para impedir a hipertensão (GoFreshSE)

14 de novembro de 2026 atualizado por: Stephen Juraschek, Beth Israel Deaconess Medical Center

GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

Visão geral do estudo

Descrição detalhada

Hypertension (HTN) affects half of US adults and is one of the most important modifiable risk factors for cardiovascular disease (CVD) and death.

The DASH diet is a proven strategy for lowering blood pressure in adults. Our proposed clinical trial will evaluate the effectiveness of a scalable solution: home-delivered, low-sodium groceries aligned with the DASH dietary pattern and ordered with dietitian assistance via a virtual supermarket, in reducing blood pressure.

Participants will be assigned to one of two 1-month long interventions: (1) dietitian-assisted, DASH-patterned, home-delivered groceries ordered weekly through Amazon Fresh (or Whole Foods) over 4 weeks or (2) self-directed grocery shopping (monthly stipend and DASH diet brochure) (referent).

Tipo de estudo

Intervencional

Inscrição (Estimado)

150

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Massachusetts
      • Boston, Massachusetts, Estados Unidos, 02215
        • Beth Israel Deaconess Medical Center

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  1. Resting systolic blood pressure of 120 to <160 mm Hg and diastolic blood pressure <110 mm Hg
  2. Resident of Florida, Georgia, and Tennessee
  3. Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 4-week period
  4. Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service
  5. Have access to mobile device or computer to be able to conduct grocery orders via video conference and send/receive text messages
  6. Willing and able to complete required measurement procedures
  7. Able to provide consent for the study
  8. Has access to a primary care team, urgent care center, or emergency room the study team can refer to for follow up care if warranted during the study

Exclusion Criteria:

A. Laboratory Exclusions:

  1. Serum potassium ≥5.4 mmol/L or <3.5 mmol/L
  2. Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
  3. Hemoglobin A1c ≥6.5%

B. Medication Exclusions:

Unstable doses (i.e. a change in the 6 months prior to screening or randomization or planning to start within study period) of the following:

  1. GLP-1 and dual GLP-1/GIP receptor agonists
  2. Anti-hypertension medications
  3. Sodium-glucose co-transporter 2 (SGLT2) inhibitors
  4. Glucose lowering medications

Use of any of the following medications:

  1. Potassium supplement, except if part of a multivitamin
  2. Warfarin (Coumadin)
  3. Chronic oral corticosteroid (intermittent use is okay)
  4. Weight loss medications (non-GLP-1 receptor agonists)
  5. Sulfonylurea or any insulin use

Any medication not compatible with participation as determined by the investigators

C. Physical Exclusions:

  1. Systolic blood pressure: <120 or ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg
  2. Arm circumference >52 cm (or the upper limit of the validated BP device)

D. Medical History Exclusions:

  1. Self-reported weight loss or gain of 15 pounds during prior 2 months
  2. Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission
  3. Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable)
  4. Gastrointestinal surgery or history that affects nutrition absorption or requires a specific diet that will deter DASH diet adherence
  5. Pregnancy or lactation or planned pregnancy during the study period
  6. Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months
  7. Hypoglycemia hospitalization in the last 12 months
  8. Any other serious illness or condition not compatible with participation as determined by the investigators

E. Lifestyle and Other Exclusions:

  1. Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
  2. Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week
  3. Active substance use disorder that would interfere with participation
  4. Extreme food insecurity
  5. Participation in or planning to start weight loss program
  6. Current participation in another clinical trial that could interfere with the study protocol
  7. Anticipated change in residence outside of eligible states prior to the end of the study
  8. Families with more than 6 adults at dinner time (children count as half an adult)

F. Investigator discretion

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Dietitian-Assisted DASH Groceries

Participants will order groceries sufficient to meet their caloric needs each week for 4 weeks with the assistance of a dietitian/nutrition interventionist. Groceries will be delivered to participants' homes or picked up at a convenient location. The dietitian/nutrition interventionist will provide brief educational content at the time of food delivery. Orders will be placed via phone or through virtual counseling sessions.

The DASH ("Dietary Approaches to Stop Hypertension"), is a healthy dietary pattern that lowers blood pressure without reducing weight. The DASH diet emphasizes fruits, vegetables, and low-fat dairy products; includes whole grains, poultry, fish, and nuts; and is reduced in red meat, sweets, and sugar-containing beverages.

Intervention Phase:

This intervention is a weekly, 4-week DASH dietary intervention. A dietitian will assist participants in ordering groceries in a pattern consistent with the DASH diet to be delivered to their homes. The quantity of groceries will be based on participant Calorie needs and family size.

Comparador Ativo: Self-directed shopping

Participants will receive a stipend and some basic information about healthy eating. The stipend is not restricted to foods.

Intervention Phase:

Participants will receive some basic information on healthy eating and a stipend during the 4-week intervention period. They are permitted to use the stipend however they choose and will not be asked about how they spent these funds.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Self-measured systolic blood pressure
Prazo: Measured before and after the 4-week intervention

This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis).

Measured before and after the 4-week intervention

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Self-measured diastolic blood pressure
Prazo: Measured before and after the 4-week intervention

This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis).

Measured before and after the 4-week intervention
Seated systolic and diastolic blood pressure (technician-measured)
Prazo: Measured before and after the 4-week intervention

Seated systolic and diastolic blood pressure measured by a technician in participants' homes, using the office blood pressure device.

Measured before and after the 4-week intervention
Body Mass Index (BMI)
Prazo: Height is measured before the intervention. Weight is measured before and after the 4-week intervention.

At home measurement based on height and weight measured by a technician via a stadiometer and scale.

Height is measured before the intervention. Weight is measured before and after the 4-week intervention.
24-hour dietary recall
Prazo: Measured before and after the 4-week intervention

Assessed via self-administered questionnaire using the Automated Self-Administered 24-Hour Dietary Recall (ASA24).

Measured before and after the 4-week intervention
Spot urine sodium/potassium ratio
Prazo: Measured before and after the 4-week intervention

Measured in urine collected at the participants' homes.

Measured before and after the 4-week intervention
Lipids
Prazo: Measured before and after the 4-week intervention

Measured in fasted serum specimens collected during phlebotomy. Includes total cholesterol, high density lipoprotein cholesterol, derived low density lipoprotein cholesterol, and triglycerides

Measured before and after the 4-week intervention
Fasting glucose
Prazo: Measured before and after the 4-week intervention

Measured in blood as part of a basic metabolic panel

Measured before and after the 4-week intervention
Serum potassium
Prazo: Measured before and after the 4-week intervention

Measured in blood as part of a basic metabolic panel

Measured before and after the 4-week intervention

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
General Health Status
Prazo: Measured before and after the 4-week intervention

Single General Health Status Question: "Would you say that in general your health is excellent, very good, good, fair, or poor?"

Measured before and after the 4-week intervention
Financial strain
Prazo: Measured before and after the 4-week intervention

We will ask the following questions: How often does this describe you? I don't have money to pay my bills (including food, housing, medical care or heating).

Never / Rarely / Sometimes / Often / Always

Measured before and after the 4-week intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

14 de outubro de 2025

Conclusão Primária (Estimado)

1 de novembro de 2026

Conclusão do estudo (Estimado)

1 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

18 de março de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

18 de março de 2025

Primeira postagem (Real)

24 de março de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

14 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • 2025P000102
  • GRT67144 (Número de outro subsídio/financiamento: American Heart Association)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever